Transcriptions

HIV, Science, and the Social

A collaborative forum for critical enquiry on HIV/AIDS and global health: experiment, ethics, and practice
Features

Treatment as Prevention: recognising the creative potential of antiretroviral medications

On the 12th of June 2012 I attended a summit organised by The International Association of Physicians in AIDS Care (IAPAC) and the British HIV Association (BHIVA). It focused on implementation challenges and opportunities of biomedical prevention, TasP and pre-exposure prophylaxis (PrEP), and was titled “Controlling the HIV Epidemic with Antiretrovirals”. The conference facilitated discussion on the use of …

AnnouncementsFeatures

New Series on the Social Dynamics of Biomedical Prevention on Transcriptions

This article is part of the series:

In the context of a growing emphasis on biomedical approaches to HIV prevention, we are seeking contributions to a new series that aims to examine the increasing biomedicalisation of HIV prevention. We are particularly interested to include contributions on the role of social research in relation to the impacts and effectiveness of implementation of biomedical technologies. As Treatment as Prevention …

Features

PrEP: time to rethink prevention, effectiveness and ethics?

This article is part of the series:

PrEP: time to rethink prevention, effectiveness and ethics?

One of the more controversial interventions proposed for HIV prevention in those who test HIV antibody negative and perceived to be at risk is pre-exposure prophylaxis (PrEP) – a daily pill comprising one or two antiretroviral drugs manufactured by Gilead Inc.  Besides the mixed results from multi-site randomised controlled trials (RCTs) seeking …